ResearcherYonsei UniversityActive in the last 2 years
Jae Woo Kim
Matched on ORCID iD 0000-0001-5456-9495; OpenAlex author ID A5100742645. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 3
- Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin leve… Co-author DOI 10.1038/s41416-023-02474-w↗
- Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum … Co-author DOI 10.1038/s41416-023-02520-7↗
- Comparison of cytologic preparation methods in endoscopic ultrasound-guided fine needle aspiration for diagnosis of pancreatic adenocarcinoma. Last author DOI 10.1016/j.pan.2016.05.006↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chang‐Hwan Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Eui Joo Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Mi‐Suk Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Hong Sik Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Y. Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Si Young Song · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Jung Hyun Jo · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Hyungsik Roger Moon · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Eun Kwang Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Dong Uk Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Seung Ok Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Young Woo Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Ho Gak Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Ho Soon Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Woo Jin Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Yong‐Tae Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
- Kyong Joo Lee · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.